KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Deferred Taxes (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Deferred Taxes data on record, last reported at $31.5 million in Q4 2025.

  • For Q4 2025, Deferred Taxes rose 574.27% year-over-year to $31.5 million; the TTM value through Dec 2025 reached $131.2 million, up 642.3%, while the annual FY2025 figure was $131.2 million, 642.3% up from the prior year.
  • Deferred Taxes reached $31.5 million in Q4 2025 per IDXX's latest filing, down from $93.2 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $93.2 million in Q3 2025 and bottomed at -$33.6 million in Q4 2023.
  • Average Deferred Taxes over 5 years is $1.0 million, with a median of -$2.2 million recorded in 2023.
  • Peak YoY movement for Deferred Taxes: plummeted 9186.81% in 2022, then surged 1461.48% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$7.4 million in 2021, then surged by 124.58% to $1.8 million in 2022, then tumbled by 1938.74% to -$33.6 million in 2023, then surged by 113.93% to $4.7 million in 2024, then surged by 574.27% to $31.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were $31.5 million in Q4 2025, $93.2 million in Q3 2025, and $2.5 million in Q2 2025.